Page 2 - Excluded Items News Today

Merck Announces First-Quarter 2021 Financial Results First-Quarter 2021 Sales Were $12.1 Billion, In-Line with First-Quarter 2020; Excluding the Impact from Foreign Exchange, Sales Declined 1% First-Quarter 2021 Sales Reflect Strong Underlying Performance of KEYTRUDA, Lynparza, BRIDION and Animal Health, Which Was Offset by COVID-19 Pandemic Impacts to Patient Access, Particularly for Vaccines First-Quarter 2021 GAAP EPS Was $1.25; First-Quarter Non-GAAP EPS Was $1.40 … First-Quarter 2021 Sa...

Fourth Quarter Fiscal 2021 Financial Summary Net sales decreased 6% from last year to $637 million with stores open about 90% of days Comparable sales increased 1% Journeys achieves record operating income Inventory down 20% Non-GAAP EPS from continuing operations was $2.76 1 Fiscal 2021 Financial Summary Highlighted by strong 74% e-commerce comp growth Generated cash flow of $134 million GAAP EPS from continuing operations was $(3.94) Non-GAAP EPS from continuing operations was $(1.18) ...

Merck Announces Fourth-Quarter and Full-Year 2020 Financial Results Fourth-Quarter 2020 Worldwide Sales Were $12.5 Billion, an Increase of 5% Fourth-Quarter 2020 GAAP Loss per Share Was $0.83, Reflecting Charges Related to Acquisitions and Intangible Asset Impairments; Fourth-Quarter Non-GAAP EPS Was $1.32 Full-Year 2020 Worldwide Sales Were $48.0 Billion, an Increase of 2%; Excluding the Impact from Foreign Exchange, Sales Grew 4% KEYTRUDA 2020 Worldwide Sales Grew 30% to $14.4 … Fourth-Qua...